T 0326/22 (CD47 antibodies/INHIBRX) of 01.08.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T032622.20240801
- Date of decision
- 1 August 2024
- Case number
- T 0326/22
- Petition for review of
- -
- Application number
- 13746964.9
- IPC class
- C07K 16/28C12P 21/08A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CD47 antibodies and methods of use thereof
- Applicant name
- Inhibrx, Inc.
- Opponent name
- Forty Seven, Inc.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 012(1)(a)Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Requirements of the EPC met - (yes)
- Catchword
- -
- Citing cases
- T 0989/23
Order
For these reasons it is decided that:
The appeal is dismissed.